Wide Ranks

GNTA

Genenta Science S.p.A.

5.38

Top Statistics
Market Cap 98 M Forward PE -8.28 Revenue Growth 0.00 %
Current Ratio 9.30 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins 0.00 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA -8.66 Enterprise / Revenue Price To Sales Trailing12 Months
Profitability
Profit Margins 0.00 % Operating Margins
Balance Sheet
Total Cash 16 M Total Cash Per Share 0.9240 Total Debt 21004
Total Debt To Equity 0.1250 Current Ratio 9.30 Book Value Per Share 0.9190
All Measures
Short Ratio 29.00 % Message Board Id finmb_282965698 Shares Short Prior Month 11610
Return On Equity -0.4289 City Milan Uuid 10554ac1-02bd-3307-8e63-2330484e6448
Previous Close 4.90 First Trade Date Epoch Utc 1 B Book Value 0.9190
Beta 0.7410 Total Debt 21004 Volume 12433
Price To Book 5.85 Fifty Two Week Low 2.20 Total Cash Per Share 0.9240
Shares Short Previous Month Date 1 B Target Median Price 20.80 Max Age 86400
Sand P52 Week Change 0.3133 Target Mean Price 20.80 Net Income To Common -8924736
Short Percent Of Float 0.0004 Implied Shares Outstanding 18 M Trailing Peg Ratio None
Last Fiscal Year End 1 B Average Daily Volume10 Day 5920 Average Volume10days 5920
Total Cash 16 M Next Fiscal Year End 1 B Held Percent Insiders 0.3868
Trailing PE 0.0000 Date Short Interest 1 B Most Recent Quarter 1 B
Regular Market Previous Close 4.90 Target Low Price 19.02 Gmt Off Set Milliseconds -18000000
Fifty Day Average 4.93 Open 4.60 Free Cashflow -4445060
State MI Dividend Yield 0.00 % Return On Assets -0.2583
Time Zone Short Name EST Trailing Eps -0.5100 Day Low 4.60
Address1 Via Olgettina No. 58 Shares Outstanding 18 M Price Hint 2
Target High Price 22.59 Website https://www.genenta.com 52 Week Change 0.0346
Average Volume 14095 Forward Eps -0.6500 Recommendation Key none
Quick Ratio 906.60 % Is_sp_500 False Regular Market Day High 5.40
Profit Margins 0.00 % Debt To Equity 0.1250 Fifty Two Week High 7.28
Day High 5.40 Shares Short 3944 Regular Market Open 4.60
Industry Key biotechnology Earnings Growth 0.00 % Revenue Growth 0.00 %
Shares Percent Shares Out 0.0002 Operating Cashflow -5683068 Currency USD
Time Zone Full Name America/New_York Market Cap 98 M Is_nasdaq_100 False
Zip 20132 Quote Type EQUITY Industry Biotechnology
Long Name Genenta Science S.p.A. Regular Market Day Low 4.60 Held Percent Institutions 0.0777
Current Price 5.38 Enterprise To Ebitda -8.66 Financial Currency EUR
Current Ratio 9.30 Industry Disp Biotechnology Number Of Analyst Opinions 2
Country Italy Float Shares 11 M Two Hundred Day Average 4.02
Enterprise Value 81 M Forward PE -8.28 Regular Market Volume 12433
Ebitda -9407693 Exchange NCM
Go to Yahoo Finance Go to Seeking Alpha 
Genenta Science S.

p.

A.

, a clinical-stage biotechnology company, engages in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors in Italy.

Its lead product candidate is Temferon, which is in Phase 1/2a clinical trials for use in the treatment of glioblastoma multiforme in patients with unmethylated MGMT gene promoter.

The company is developing Temferon for use in the treatment of other solid tumor indications, locally advanced hepatocellular carcinoma, and intra-hepatic cholangiocarcinoma.

In addition, it develops biologic platform to deliver immunomodulatory molecules directly to the tumor by infiltrating monocytes/macrophages.

Genenta Science S.

p.

A.

was incorporated in 2014 and is headquartered in Milan, Italy.